• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 11-K filed by Cardinal Health Inc.

    6/21/24 8:24:38 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care
    Get the next $CAH alert in real time by email
    11-K 1 a24q4_11kx123123xform11-kx.htm 11-K Document
    Table of Contents

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 11-K
    þANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    For the fiscal year ended December 31, 2023
    or
    oTRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    For the transition period from ________ to ________
    Commission File Number 1-11373
    A.Full title of the plan and the address of the plan, if different from that of the issuer named below:
    Cardinal Health 401(k) Savings Plan
    B.Name of the issuer of the securities held pursuant to the plan and the address of its principal executive office:
    Cardinal Health, Inc.
    7000 Cardinal Place
    Dublin, Ohio 43017




    Cardinal Health 401(k) Savings Plan
    Financial Statements and Supplemental Schedule
    Years Ended December 31, 2023 and 2022
    Table of Contents
    Report of Independent Registered Public Accounting Firm
    1
    Financial Statements:
    Statements of Net Assets Available for Benefits
    2
    Statements of Changes in Net Assets Available for Benefits
    3
    Notes to Financial Statements
    4
    Supplemental Schedule*:
    Schedule H, Line 4i on Form 5500: Schedule of Assets (Held at End of Year)
    11
    Signature
    12
    Exhibit:
    Consent of Independent Registered Public Accounting FirmExhibit 23.1
    *All other financial schedules required by Section 2520.103-10 of the U.S. Department of Labor’s Annual Reporting and Disclosure Requirements under the Employee Retirement Income Security Act of 1974, as amended, have been omitted because they are not applicable.



    Table of Contents
    Report of Independent Registered Public Accounting Firm
    To the Plan Participants and the Plan Administrator of Cardinal Health 401(k) Savings Plan
    Opinion on the Financial Statements
    We have audited the accompanying statements of net assets available for benefits of Cardinal Health 401(k) Savings Plan (the Plan) as of December 31, 2023 and 2022, and the related statements of changes in net assets available for benefits for the years then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan at December 31, 2023 and 2022, and the changes in its net assets available for benefits for the years then ended, in conformity with U.S. generally accepted accounting principles.
    Basis for Opinion
    These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on the Plan’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
    We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Plan’s internal control over financial reporting. Accordingly, we express no such opinion.
    Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
    Supplemental Schedule Required by ERISA
    The accompanying supplemental schedule of assets (held at end of year) as of December 31, 2023 (referred to as the “supplemental schedule”), has been subjected to audit procedures performed in conjunction with the audit of the Plan’s financial statements. The information in the supplemental schedule is the responsibility of the Plan’s management. Our audit procedures included determining whether the information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental schedule. In forming our opinion on the information, we evaluated whether such information, including its form and content, is presented in conformity with the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the information is fairly stated, in all material respects, in relation to the financial statements as a whole.
    /s/ Ernst & Young LLP
    We have served as the Plan's auditor since 2002.
    Grandview Heights, Ohio
    June 21, 2024


    1

    Table of Contents

    Cardinal Health 401(k) Savings Plan
    Statements of Net Assets Available for Benefits
    December 31, 2023 and 2022
     20232022
    Assets
    Plan’s interest in Stable Value Master Trust$374,982,080 $406,659,338 
    Investments at fair value3,839,568,662 3,235,061,067 
    Accrued income1,161,761 1,212,387 
    Receivables:
    Notes receivable from participants68,006,160 65,997,504 
    Company contributions1,448,613 1,303,715 
    Participant contributions— 20,568 
    Pending trades1,003,741 447,696 
    Total receivables70,458,514 67,769,483 
    Total assets4,286,171,017 3,710,702,275 
    Liabilities
    Accrued fees34,286 22,446 
    Pending trades payable1,679,441 13,457 
    Total liabilities1,713,727 35,903 
    Net assets available for benefits$4,284,457,290 $3,710,666,372 
    The accompanying notes are an integral part of these financial statements.
    2

    Table of Contents
    Cardinal Health 401(k) Savings Plan
    Statements of Changes in Net Assets Available for Benefits
    For the Years Ended December 31, 2023 and 2022
    20232022
    Additions to net assets attributed to:
    Investment income (loss):
    Plan's interest in Stable Value Master Trust's net investment income$10,337,520 $7,884,390 
    Net appreciation (depreciation) in the fair value of investments682,378,043 (733,043,023)
    Interest and dividends16,302,500 31,392,146 
    Total investment income (loss)709,018,063 (693,766,487)
    Interest income on notes receivable from participants3,854,571 2,985,206 
    Contributions:
    Company75,500,734 69,354,119 
    Participant158,134,878 150,075,877 
    Rollovers28,551,911 31,444,456 
    Total contributions262,187,523 250,874,452 
    Total additions (reductions), net975,060,157 (439,906,829)
    Deductions from net assets attributed to:
    Benefits paid to participants399,271,880 408,342,657 
    Administrative expenses1,997,359 2,095,056 
    Total deductions401,269,239 410,437,713 
    Net increase (decrease)573,790,918 (850,344,542)
    Net assets available for benefits:
    Beginning of year3,710,666,372 4,561,010,914 
    End of year$4,284,457,290 $3,710,666,372 
    The accompanying notes are an integral part of these financial statements.
    3

    Table of Contents

    Cardinal Health 401(k) Savings Plan
    Notes to Financial Statements
    December 31, 2023 and 2022
    1. Description of Plan
    General
    The Cardinal Health 401(k) Savings Plan (the “Plan”) is a defined contribution plan, covering substantially all U.S. employees of Cardinal Health, Inc. (the “Company”) and certain of its subsidiaries. Employees who are covered by a collective bargaining agreement are not eligible to participate, unless the agreement provides for participation, and employees who are covered by the Cardinal Health 401(k) Savings Plan for Employees of Puerto Rico are not eligible to participate. Eligible employees participate upon their date of hire. The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”).
    The Cardinal Health Stable Value Fund (the “Stable Value Master Trust”) was established for the Plan and certain other plans of the Company. See Note 3 for more information regarding the Stable Value Master Trust.
    Effective January 1, 2020, the Plan was amended and restated in compliance with the Internal Revenue Code of 1986, as amended (the “Code”).
    The description of the Plan provides only general information. Participants should refer to the Plan document for a more complete description of the Plan’s provisions.
    Administration
    The Company’s Financial Benefit Plans Committee (the “Committee”) is the Plan administrator and is responsible for the general operation and administration of the Plan.
    Principal Financial Group and certain of its affiliates perform the recordkeeping, trustee, and asset custodian duties.
    Contributions
    Contributions that may be made to the Plan include participant elective contributions, rollover contributions, Company matching, discretionary employer, and discretionary special contributions.
    Participants may elect to contribute up to 50% of their eligible compensation (subject to certain limitations), as defined by the Plan document. Participants who have or will attain at least age 50 by the end of the plan year may elect to contribute up to an additional $7,500 and $6,500 in 2023 and 2022, respectively, as a catch-up contribution. Participants may also roll over amounts representing distributions from other qualified plans. Participant contributions may be contributed on a pre-tax basis or as “Roth” contributions or as a combination of the two, subject to applicable limitations. Rollover contributions may also include Roth rollovers.
    The Company match is 200% of each participant’s compensation deferral contributions that do not exceed 1% of the participant’s compensation, and 50% of each participant’s compensation deferral contributions that exceed 1% of the participant’s compensation but that do not exceed 5% of the participant’s compensation. Matching contributions are allocated on an aggregate basis to both pre-tax and Roth elective contributions, subject to the matching limitations in the preceding sentences.
    In addition, the Company may elect to make discretionary employer contributions and/or discretionary special contributions. Discretionary employer contributions are allocated to participants based generally on their proportionate share of total eligible compensation and eligible compensation above the Social Security taxable wage base amount for the year of allocation.
    The Plan’s discretionary employer contribution is determined at the discretion of the Human Resources and Compensation Committee of the Company’s Board of Directors or such other committee, entity, or person authorized by the Human Resources and Compensation Committee for such purposes. To be eligible for the discretionary employer contribution, participants generally must be employed on the last day of the Company’s fiscal year, June 30.
    The discretionary employer contribution is calculated on eligible compensation received during the Company’s fiscal year ending within the plan year for which the discretionary employer contribution is made to the Plan. No discretionary employer contributions were made to the Plan for the years ended December 31, 2023 and 2022.
    The Plan’s discretionary special contributions, if any, are allocated to the participants in the eligible group ratably based on their proportionate share of the total eligible compensation in that group. No discretionary special contributions were made to the Plan for the years ended December 31, 2023 and 2022.

    4

    Table of Contents
    Notes to Financial Statements
    1. Description of Plan (continued)
    Contributions (continued)
    Participants direct the investment of their contributions into various investment options offered by the Plan. The Company’s matching, discretionary employer and discretionary special contributions, if any, are also invested as directed by participants.
    Participant Accounts
    Each participant’s account is credited with the participant’s elective contributions, any rollover contributions made by the participant, and allocations of the Company’s contributions and Plan earnings or losses. A participant is entitled to the benefit provided from the participant’s vested account balance.
    Vesting
    Participants are 100% vested immediately in their elective deferral, rollover, and Company matching contributions, plus actual earnings thereon. A participant is 100% vested in the Company’s discretionary employer and discretionary special contributions after three years of vesting service, or if the participant dies, becomes totally disabled, or reaches retirement age, as defined by the Plan document, while employed by the Company. The Plan provides for the partial vesting of the Company contributions to non-highly compensated participants with more than one year, but less than three years, of vesting service, who were terminated as part of a designated reduction in workforce, as defined in the Plan document.
    Forfeitures
    Non-vested account balances are generally forfeited either upon full distribution of vested balances or completion of five consecutive one-year breaks in service, as defined by the Plan document. Forfeitures may be used to either reduce Company contributions to the Plan or to pay reasonable expenses of the Plan as determined by the Committee.
    Forfeitures used to reduce Company contributions and pay reasonable expenses of the Plan were $680,997 and $2,468,168 during 2023 and 2022, respectively. At December 31, 2023 and 2022, the forfeited non-vested accounts were $235,583 and $42,643, respectively.
    Administrative Expenses
    Administrative expenses are paid by the Company or from the assets of the Plan. General expenses paid from the Plan’s assets are allocated among participant accounts to the extent not paid from forfeitures, except for fees for loans, withdrawals, and Qualified Domestic Relations Orders, which are paid from the account of the participant incurring the expense.
    For the year ended December 31, 2022, revenue sharing and sub-transfer agent fee income received by the Plan was credited to the accounts of participants who held revenue sharing and sub-transfer income investments. Participants earned $247,825 in revenue sharing and sub-transfer agent fee income for the year ended December 31, 2022. Effective January 1, 2023, changes in the fee structure eliminated these sources of income for the Plan.
    Participant Loans
    Participants may borrow from their fund accounts a minimum of $1,000 up to a maximum equal to the lesser of $50,000, less the highest outstanding loan balance during the prior 12 months or 50% of their vested account balance. Loan terms primarily range from 1 to 5 years for general purposes, or up to 15 years for the purchase of a primary residence. Participant loans are secured by 50% of the vested balance in the participant’s account as of the date of the loan and bear interest at a reasonable rate, as established by the Committee, currently Prime plus 1%, which is set for the life of the loan. Interest rates for new loans are subject to change on a monthly basis. Loan repayments, including interest and applicable loan fees, are generally repaid through payroll deductions.
    Payment of Benefits
    Upon termination of employment, death, retirement or total disability, distributions are generally made in the form of a lump-sum payment or installments. In addition, the Plan includes a provision for participants to make withdrawals from their rollover contributions account at any time, elective contributions account under certain hardship circumstances, or their account after attaining age 59 1/2, as defined in the Plan document. Required qualified joint and survivor annuity payment options are preserved for the portion of participant accounts transferred to the Plan from a money purchase pension plan, if any.
    5

    Table of Contents
    Notes to Financial Statements
    2. Summary of Significant Accounting Policies
    Basis of Presentation
    The financial statements of the Plan are prepared on the accrual basis of accounting in accordance with U.S. generally accepted accounting principles (“GAAP”).
    Use of Estimates
    The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the financial statements and accompanying notes and supplemental schedules. Actual results could differ from those estimates.
    Investment Valuation and Income Recognition
    Plan investments, except for fully benefit-responsive investment contracts (see Note 3), are reported at fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. See Note 4 for discussion of fair value measurements.
    Purchases and sales of securities are recorded on a trade-date basis using fair market value, except for those investments in investment contracts that are transacted at contract value. Dividends are recorded on the ex-dividend date. Interest is recorded on the accrual basis. Net appreciation (depreciation) includes the Plan’s gains and losses on investments bought and sold, as well as held, during the year.
    Contributions
    Contributions from Plan participants, and the related matching contributions from the Company, are recorded in the year in which the employee contributions are withheld from compensation.
    Notes Receivable from Participants
    Notes receivable from participants represent participant loans that are recorded at their unpaid principal balance, plus any accrued but unpaid interest. Interest income on notes receivable from participants is recorded when it is earned. Related fees are recorded as administrative expenses and are expensed when they are incurred. If a participant ceases to make loan repayments and the Plan sponsor deems the participant loan to be a distribution, the participant loan balance is retained as a defaulted loan amount until a distributable event occurs, at which time the loan amount is offset from the value of the account.
    Payment of Benefits
    Benefit payments are recorded when paid.
    6

    Table of Contents
    Notes to Financial Statements
    3. Assets Held in the Stable Value Master Trust
    Certain of the Plan’s investments are held in the Stable Value Master Trust, which was established for the investment of assets of the Plan and other Company-sponsored retirement plans. Each participating plan’s interest in the investment funds (i.e., separate accounts) of the Stable Value Master Trust is based on account balances of the participants and their elected investment funds. The Stable Value Master Trust’s assets are allocated among the participating plans by assigning to each plan those transactions (primarily contributions, benefit payments, and plan-specific expenses) that can be specifically identified and by allocating among all plans, in proportion to the fair value of the assets assigned to each plan, income and expenses resulting from the collective investment of the assets of the Stable Value Master Trust. The Plan’s interest in the Stable Value Master Trust’s net investment income presented in the Statements of Changes in Net Assets Available for Benefits consists of the unrealized and realized gains (losses) and the earnings on those investments.
    The Stable Value Master Trust holds synthetic investment contracts which meet the fully benefit-responsive investment contract criteria and therefore are reported at contract value. Contract value is the relevant measure for fully benefit-responsive investment contracts, because this is the amount received by participants if they were to initiate permitted transactions under the terms of the Plan. Contract value represents contributions made under each contract, plus earnings, less participant withdrawals, and administrative expenses.
    The Plan owns the underlying investments of the synthetic investment contracts. A synthetic investment contract includes a wrapper contract, which is an agreement for the wrap issuer, such as a bank or insurance company, to make payments to the Plan in certain circumstances. The wrapper contract typically includes certain conditions and limitations on the underlying assets owned by the Plan. Synthetic investment contracts are designed to accrue interest based on crediting rates established by the contract issuers.
    The synthetic investment contracts held by the Plan include wrapper contracts which provide a guarantee that the credit rate will not fall below 0%. Cash flow volatility (e.g., timing of benefit payments), as well as asset underperformance, can be passed through to the Plan through adjustments to future contract crediting rates. Formulas are provided in the contracts that adjust renewal crediting rates to recognize the difference between fair value and the book value of the underlying assets. Crediting rates are reviewed quarterly for resetting.
    The Plan’s ability to receive amounts due in accordance with fully benefit-responsive investment contracts is dependent on the third-party issuers’ ability to meet their financial obligations. The issuers’ ability to meet their contractual obligations may be affected by future economic and regulatory developments.
    Certain events might limit the ability of the Plan to transact at contract value with the contract issuers. These events may be different under each contract. Examples of such events include the following:
    •Plan disqualification under the Code;
    •Establishment of a defined contribution plan by the Company that competes for participant contributions;
    •Material amendments to the Plan or administration as to investment options, transfer procedures, or withdrawals;
    •Company’s inducement to participants to withdraw or transfer funds from the contract;
    •Termination or partial termination of the Plan;
    •Group termination, layoff, early retirement incentive program, or other downsizing by the Company;
    •Merger or consolidation of the Plan with another plan or spin-off of any portion of the Plan’s assets to another Plan; and
    •Any changes in law, regulation, ruling, or administrative or judicial position that, in the issuer’s reasonable determination, could result in substantial disbursements from the contract.
    No events are probable of occurring that might limit the ability of the Plan to transact at contract value with the contract issuers and that also would limit the ability of the Plan to transact at contract value with the participants.
    In addition, certain events allow the issuers to terminate the contacts with the Plan and settle at an amount different from contract value. Those events may be different under each contract. Examples of such events include the following:
    •The investment manager or trustee breaches any of its material obligations under the agreement;
    •Any representation of the investment manager is or becomes untrue in any material respect;
    •The investment manager with respect to the contract is terminated, unless a qualified professional manager is duly appointed and is agreed to by the issuer;
    •The issuer determines that the execution, delivery, or performance of the contract constitutes or will constitute a prohibited transaction;
    •Failure to pay amounts due to the issuer; and
    •Termination of the Plan, or disqualification of the trust.
    Each investment contract is subject to early termination penalties that may be significant. There are no reserves against contract value for credit risk of the contract issuers or other matters.

    7

    Table of Contents
    Notes to Financial Statements
    3. Assets Held in the Stable Value Master Trust (continued)
    The Stable Value Master Trust also holds a stable value common collective trust that is composed primarily of fully benefit-responsive investment contracts and is valued at the net asset value of units of the collective trust. The common collective trust is designed to deliver safety and stability by preserving principal and accumulating earnings. The net asset value is used as a practical expedient to estimate fair value. This practical expedient would not be used if it is determined to be probable that the fund will sell the investment for an amount different from the reported net asset value. Participant transactions (purchases and sales) may occur daily. If the Plan initiates a full redemption of the collective trust, the issuer reserves the right to require a one-year notice to ensure that securities liquidations will be carried out in an orderly business manner. The Plan has no contractual obligations to further invest in the fund.
    The assets held in the Stable Value Master Trust were as follows for the years ended December 31, 2023 and 2022:
     2023
     Master Trust
    Balance
    Plan's Interest in Master Trust Balance ($)Plan's Interest in Master Trust Balance (%)
    Fully benefit-responsive synthetic investment contracts - at contract value$368,169,174 $362,556,495 98 %
    Common collective trusts - at fair value13,107,406 12,907,586 98 %
          Total Master Trust investments381,276,580 375,464,081 98 %
    Cash and pending activity(489,463)(482,001)98 %
          Total Master Trust net assets$380,787,117 $374,982,080 98 %
     2022
     Master Trust
    Balance
    Plan's Interest in Master Trust Balance ($)Plan's Interest in Master Trust Balance (%)
    Fully benefit-responsive synthetic investment contracts - at contract value$399,055,837 $393,953,859 99 %
    Common collective trusts - at fair value13,575,222 13,401,661 99 %
          Total Master Trust investments412,631,059 407,355,520 99 %
    Cash and pending activity(705,198)(696,182)99 %
          Total Master Trust net assets$411,925,861 $406,659,338 99 %
    The investment income of the Stable Value Master Trust was as follows for the years ended December 31, 2023 and 2022:
     2023
     Master Trust
    Balance
    Plan's Interest in Master Trust Balance ($)Plan's Interest in Master Trust Balance (%)
    Net investment income$10,481,766 $10,337,520 99 %
    Total investment income10,481,766 10,337,520 99 %
     2022
     Master Trust
    Balance
    Plan's Interest in Master Trust Balance ($)Plan's Interest in Master Trust Balance (%)
    Net investment income$7,991,184 $7,884,390 99 %
    Total investment income7,991,184 7,884,390 99 %
    8

    Table of Contents
    Notes to Financial Statements
    4. Fair Value Measurements
    Accounting Standards Codification ("ASC") 820, Fair Value Measurement, provides the framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described as follows:
    Level 1:    Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Plan has the ability to access.
    Level 2:    Inputs to the valuation methodology include:
    •quoted prices for similar assets or liabilities in active markets;
    •quoted prices for identical or similar assets or liabilities in inactive markets;
    •inputs other than quoted prices that are observable for the asset or liability; and
    •inputs that are derived principally from or corroborated by observable market data by correlation or other means.
    If the asset or liability has a specified (contractual) term, the level 2 input must be observable for substantially the full term of the asset or liability.
    Level 3:    Inputs to the valuation methodology are unobservable and significant to the fair value measurement.
    The asset’s or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.
    Following is a description of the valuation techniques and inputs used for each general type of assets measured at fair value. There have been no changes in the methodologies used at December 31, 2023 and 2022.
    Mutual funds and common shares fair values are determined utilizing quoted market prices reported on the active market on which they are traded.
    The common collective trusts (“CCTs”) are valued utilizing the respective net asset values as reported by such trusts, which are reported at fair value. The net asset value is used as a practical expedient to estimate fair value. The fair value has been determined by the trustee sponsoring the CCT by dividing the trust’s net assets at fair value by its units outstanding at the valuation dates. There are no restrictions as to the redemption of these investments, nor does the Plan have any contractual obligations to further invest in any of these CCTs.
    The preceding methods described may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, although the Plan believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.
    The following tables set forth by level, within the fair value hierarchy, the fair value of the Plan’s assets held outside of the Stable Value Master Trust as of December 31, 2023 and 2022:
     December 31, 2023
     Level 1Level 2Level 3Total
    Mutual funds$517,052,922 $— $— $517,052,922 
    Cardinal Health, Inc., common shares231,848,064 — — 231,848,064 
    Total assets in the fair value hierarchy$748,900,986 $— $— $748,900,986 
    Common collective trusts measured at net asset value3,090,667,676 
    Total assets at fair value$3,839,568,662 
     December 31, 2022
     Level 1Level 2Level 3Total
    Mutual funds$461,843,014 $— $— $461,843,014 
    Cardinal Health, Inc., common shares186,327,807 — — 186,327,807 
    Total assets in the fair value hierarchy$648,170,821 $— $— $648,170,821 
    Common collective trusts measured at net asset value2,586,890,246 
    Total assets at fair value$3,235,061,067 
    9

    Table of Contents
    Notes to Financial Statements
    5. Income Tax Status
    On September 22, 2017, the Plan received a determination letter from the Internal Revenue Service (the “IRS”) based on plan amendments through December 4, 2015, stating that the Plan is qualified under Section 401(a) of the Code and, therefore, the related trust is exempt from taxation. The Plan was subsequently amended. Once qualified, the Plan is required to operate in conformity with the Code to maintain its qualified status. The plan administrator believes the Plan is being operated in compliance with the applicable requirements of the Code and, therefore, believes the Plan is qualified and the related trust is tax-exempt.
    GAAP requires plan management to evaluate uncertain tax positions taken by the Plan. The financial statement effects of a tax position are recognized when the position is more likely than not, based on the technical merits, to be sustained upon examination by the IRS. The Plan administrator has analyzed the tax positions taken by the Plan, and has concluded that as of December 31, 2023 and 2022, there are no uncertain positions taken or expected to be taken. The Plan has recognized no interest or penalties related to uncertain tax positions. The Plan is subject to routine audits by taxing jurisdictions; however, there are currently no audits for any tax periods in progress.
    6. Risks and Uncertainties
    The Plan invests in various investment securities. Investment securities are exposed to various risks, such as interest rate, credit and overall market volatility risk. Market risks include global events which could impact the value of investment securities, such as pandemic or international conflict. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect participants’ account balances and the amounts reported in the Statements of Net Assets Available for Benefits.
    7. Plan Termination
    Although it has not expressed any intent to do so, the Company has the right under the Plan to discontinue its contributions at any time and to terminate the Plan subject to the provisions of ERISA. In the event of Plan termination, participants will become 100% vested in their accounts.
    8. Related Party and Parties-in-Interest Transactions
    The Plan held $231,848,064 and $186,327,807 of Cardinal Health, Inc. common shares at December 31, 2023 and 2022, respectively.
    9. Reconciliation of Financial Statements to Form 5500
    The following is a reconciliation of net assets available for benefits per the financial statements to Form 5500:
     December 31
     20232022
    Net assets available for benefits per the financial statements$4,284,457,290 $3,710,666,372 
    Amounts allocated to withdrawing participants(185,238)(54,464)
    Net assets available for benefits per Form 5500$4,284,272,052 $3,710,611,908 
    The following is a reconciliation of benefit payments per the financial statements to Form 5500:
    2023
    Benefits payments per the financial statements$399,271,880 
    Amounts allocated to withdrawing participants:
      At December 31, 2022(54,464)
      At December 31, 2023185,238 
    Net deemed distributions(257,336)
    Benefits paid to participants per Form 5500$399,145,318 

    The following is a reconciliation of the net increase in net assets available for benefits per the financial statements to Form 5500:
     2023
    Net increase in assets per the financial statements$573,790,918 
    Change in amounts allocated to withdrawing participants(130,774)
    Net income per Form 5500$573,660,144 

    10

    Table of Contents

    Cardinal Health 401(k) Savings Plan
    Schedule H, Line 4i on Form 5500: Schedule of Assets (Held at End of Year)*
    December 31, 2023
    EIN: 31-0958666 Plan Number: 055
    (a)(b)(c)(e)
     Identity of issuer, borrower, lessor or similar partyDescription of investment, including maturity
    date, rate of interest, maturity or par value
    Current
    value
    Mutual funds:
    Dodge & Cox Stock Fund 445,390,875 
    PIMCOAll Asset Fund Institutional71,662,047 
    Common collective trusts:
    Fidelity Management Trust CompanyGrowth Company Commingled Pool706,050,748 
    **Vanguard Fiduciary Trust Company500 Index Trust566,311,033 
    Fidelity Institutional Asset Management Trust Co.
    FIAM Group Trust for Employee Benefit Plans Small Capitalization Core Commingled Pool338,749,526 
    Fidelity Management Trust CompanyDiversified International Commingled Pool 261,790,841 
    SEI Trust CompanyPIMCO Total Return Collective Trust259,877,652 
    **Vanguard Fiduciary Trust CompanyTotal International Stock Market Index Trust239,344,804 
    **Vanguard Fiduciary Trust CompanyTotal Stock Market Index Trust 205,664,597 
    **BlackRock Institutional Trust CompanyGlobal Allocation Collective Fund105,080,353 
    **Vanguard Fiduciary Trust CompanyExtended Market Index Trust77,313,225 
    JPMorgan Chase BankCommingled Pension Trust Fund (Diversified Commercial Property)75,571,232 
    **Vanguard Fiduciary Trust CompanyTotal Bond Market Index Trust 70,671,562 
    **BlackRock Institutional Trust CompanyU.S. TIPS Non-Lendable Fund67,836,922 
    Loomis Sayles Trust CompanyHigh Yield Conservative Trust48,891,995 
    SEI Trust CompanyAxiom Emerging Markets Trust37,681,747 
    Wellington Trust CompanyOpportunistic Emerging Markets Debt Portfolio24,678,517 
    SEI Trust CompanyShort-Term Investment Fund5,152,922 
    Common shares:
    **Cardinal Health, Inc.Common shares231,848,064 
    Loans:
    **Participant loansVarious maturity dates, with interest rates ranging from 4.25% to 9.50%68,006,160 
    Total$3,907,574,822 
    *Other columns required by the U.S. Department of Labor’s Annual Reporting and Disclosure Requirements under ERISA have been omitted because they are not applicable.
    **Denotes party-in-interest.

    11

    Table of Contents

    Signature
    Pursuant to the requirements of the Securities Exchange Act of 1934, the members of the Committee have duly caused this annual report to be signed on its behalf by the undersigned thereunto duly authorized.
    Cardinal Health 401(k) Savings Plan
    Date:June 21, 2024/s/ CASEY FORDYCE
    Casey Fordyce
    Financial Benefit Plans Committee Member

    12
    Get the next $CAH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CAH

    DatePrice TargetRatingAnalyst
    1/9/2026Neutral → Buy
    Citigroup
    12/9/2025$243.00Overweight
    Barclays
    6/3/2025$179.00Equal Weight → Overweight
    Wells Fargo
    2/5/2025$140.00 → $150.00Hold → Buy
    Jefferies
    1/8/2025$130.00 → $144.00Hold → Buy
    TD Cowen
    1/7/2025$140.00In-line → Outperform
    Evercore ISI
    1/6/2025$132.00 → $145.00Neutral → Buy
    BofA Securities
    12/13/2024$101.00 → $127.00Underweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $CAH
    SEC Filings

    View All

    SEC Form 10-Q filed by Cardinal Health Inc.

    10-Q - CARDINAL HEALTH INC (0000721371) (Filer)

    2/5/26 8:47:09 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CARDINAL HEALTH INC (0000721371) (Filer)

    2/5/26 6:47:19 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CARDINAL HEALTH INC (0000721371) (Filer)

    1/13/26 6:53:33 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cardinal Health upgraded by Citigroup

    Citigroup upgraded Cardinal Health from Neutral to Buy

    1/9/26 8:24:26 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Barclays initiated coverage on Cardinal Health with a new price target

    Barclays initiated coverage of Cardinal Health with a rating of Overweight and set a new price target of $243.00

    12/9/25 8:43:24 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Cardinal Health from Equal Weight to Overweight and set a new price target of $179.00

    6/3/25 7:24:57 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cardinal Health Board of Directors Approves Quarterly Dividend

    DUBLIN, Ohio, Feb. 12, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on April 15, 2026 to shareholders of record at the close of business on April 1, 2026. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuc

    2/12/26 4:45:00 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health Reports Second Quarter Fiscal Year 2026 Results and Raises Outlook

    Revenue increased 19% to $65.6 billionGAAP1 operating earnings increased 29% to $707 million; GAAP diluted EPS increased 19% to $1.97Non-GAAP operating earnings increased 38% to $877 million; non-GAAP diluted EPS increased 36% to $2.63Cardinal Health raises fiscal year 2026 non-GAAP EPS guidance2 to $10.15 to $10.35Cardinal Health completes annual baseline share repurchase of $750 millionCardinal Health reaches targeted leverage range3DUBLIN, Ohio, Feb. 5, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2026 revenues of $65.6 billion, an increase of 19% from the second quarter of fiscal year 2025. Second quarter GAAP operating earnings increased 29%

    2/5/26 6:45:00 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health Raises Fiscal 2026 Outlook and Highlights Strategic Progress During J.P. Morgan Healthcare Conference Presentation

    Raising Fiscal 2026 Outlook: Cardinal Health is increasing expectations for fiscal year 2026 non-GAAP diluted earnings per share (EPS)1 to at least $10.00, from its prior guidance range of $9.65 to $9.85Accelerating Specialty Growth: The company expects that its Specialty revenues will surpass $50 billion in fiscal 2026, marking a 16% compounded annual growth rate (CAGR) over three years2Successfully Navigating IRA Changes: The company confirms the successful transition of its manufacturer distribution service agreements for all branded pharmaceutical products impacted by the 2026 Medicare Drug Price Negotiation ProgramIntroducing ContinuCare™ Pathway: The company's direct-to-patient at-Home

    1/13/26 6:50:00 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hall Patricia Hemingway sold $918,880 worth of shares (4,000 units at $229.72), decreasing direct ownership by 12% to 28,264 units (SEC Form 4)

    4 - CARDINAL HEALTH INC (0000721371) (Issuer)

    2/10/26 4:13:00 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Chief Human Resources Officer Pitteroff Valerie Christine was granted 3,982 shares, increasing direct ownership by 99% to 8,022 units (SEC Form 4)

    4 - CARDINAL HEALTH INC (0000721371) (Issuer)

    1/20/26 7:21:53 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    New insider Pitteroff Valerie Christine claimed ownership of 4,503 shares (SEC Form 3)

    3 - CARDINAL HEALTH INC (0000721371) (Issuer)

    1/7/26 4:10:22 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    Leadership Updates

    Live Leadership Updates

    View All

    After Major Oncology Conference, All Eyes Turn to Industry Innovation

    USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /PRNewswire/ -- After the close of the world's largest cancer conference (the 2025 American Society of Clinical Oncology annual meeting), doctors, scientists, and researchers are optimistic, especially in the fields of immunotherapy, Car T-cell therapy, liquid biopsies, breast cancer, AI, and even exercise. However, with reports coming out that the current US administration could drastically reduce funding of the National Cancer Institute (NCI) by nearly 40%, the market is looking towards the private sector to pick up the slack and continue to make advancements in cancer treatment. For inv

    6/12/25 9:00:00 AM ET
    $CAH
    $CTOR
    $CTXR
    Other Pharmaceuticals
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Carlisle Companies Announces Leadership Appointments

    Carlisle Companies Incorporated (NYSE:CSL) today announced the appointment of Christopher B. Gaskill as Vice President & General Counsel for the Company. In conjunction with this appointment, Scott C. Selbach will transition to a new role as Executive Vice President, Government Relations for the Company. Mr. Selbach will also remain Secretary of the Company. Both Mr. Gaskill and Mr. Selbach will report to Chris Koch, Carlisle's Chair, President & Chief Executive Officer. Prior to joining Carlisle, Mr. Gaskill served as Executive Vice President, Chief Legal Officer, and Secretary at Summit Materials, Inc. (NYSE:SUM), where he was responsible for the company's global legal functions and ensu

    5/16/25 4:05:00 PM ET
    $CAH
    $CSL
    $SUM
    Other Pharmaceuticals
    Health Care
    Specialty Chemicals
    Industrials

    Robert Musslewhite and Sudhakar Ramakrishna to join Cardinal Health Board of Directors

    DUBLIN, Ohio, March 10, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors has elected Robert Musslewhite, former Chief Executive Officer of Definitive Healthcare Corp., and Sudhakar Ramakrishna, President and Chief Executive Officer of SolarWinds Corporation, as independent directors, effective March 7, 2025. With more than 20 years of leadership experience, including serving as CEO for two publicly traded companies, Mr. Musslewhite brings to the board unique expertise in advanced analytics, data, and technology across the healthcare e

    3/10/25 6:45:00 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    Financials

    Live finance-specific insights

    View All

    Cardinal Health Board of Directors Approves Quarterly Dividend

    DUBLIN, Ohio, Feb. 12, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on April 15, 2026 to shareholders of record at the close of business on April 1, 2026. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuc

    2/12/26 4:45:00 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health Reports Second Quarter Fiscal Year 2026 Results and Raises Outlook

    Revenue increased 19% to $65.6 billionGAAP1 operating earnings increased 29% to $707 million; GAAP diluted EPS increased 19% to $1.97Non-GAAP operating earnings increased 38% to $877 million; non-GAAP diluted EPS increased 36% to $2.63Cardinal Health raises fiscal year 2026 non-GAAP EPS guidance2 to $10.15 to $10.35Cardinal Health completes annual baseline share repurchase of $750 millionCardinal Health reaches targeted leverage range3DUBLIN, Ohio, Feb. 5, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2026 revenues of $65.6 billion, an increase of 19% from the second quarter of fiscal year 2025. Second quarter GAAP operating earnings increased 29%

    2/5/26 6:45:00 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health Board of Directors Approves Quarterly Dividend

    DUBLIN, Ohio, Nov. 4, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on January 15, 2026 to shareholders of record at the close of business on January 2, 2026. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of

    11/4/25 4:45:00 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Cardinal Health Inc. (Amendment)

    SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)

    2/13/24 5:01:02 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G/A filed by Cardinal Health Inc. (Amendment)

    SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)

    1/30/24 1:39:03 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G/A filed by Cardinal Health Inc. (Amendment)

    SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)

    2/14/23 12:37:58 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care